phenylacetic acid has been researched along with Lymphoma, Non-Hodgkin in 1 studies
phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
Excerpt | Relevance | Reference |
---|---|---|
" The goals of this study were to determine whether PA and PB (a) are cytotoxic to malignant B cells from patients with non-Hodgkin's lymphoma and B-cell chronic lymphocytic leukemia and (b) exhibit additive or synergistic induction of apoptosis when administered to myeloma cell lines in combination with conventional drugs." | 1.31 | Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents. ( Kaufmann, SH; Stenson, M; Svingen, PA; Timm, M; Witzig, TE, 2000) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Witzig, TE | 1 |
Timm, M | 1 |
Stenson, M | 1 |
Svingen, PA | 1 |
Kaufmann, SH | 1 |
1 other study available for phenylacetic acid and Lymphoma, Non-Hodgkin
Article | Year |
---|---|
Induction of apoptosis in malignant B cells by phenylbutyrate or phenylacetate in combination with chemotherapeutic agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Division; Cell Survival; Drug Interactions; Drug Synergism; H | 2000 |